Strata Critical Medical (SRTA) Proxy Filing summary

Executive summary

• Annual meeting scheduled for May 6, 2025, with virtual participation available to shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 5, 2025.

Voting matters and shareholder proposals

• Election of three Class I directors for terms expiring in 2028: John Borthwick, Reginald Love, and Edward Philip.

• Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2025.

• Advisory vote on the frequency of future advisory votes on executive compensation, with a recommendation for annual votes.

• Advisory vote on the compensation of named executive officers.

• Provision for other business to be addressed as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends all director nominees and proposals for shareholder approval.